![](https://assets.cambridge.org/97805217/60584/cover/9780521760584.jpg)
Book contents
- Next Generation Antidepressants
- Next Generation Antidepressants
- Copyright page
- Contents
- Contributors
- Preface
- Abbreviations
- Chapter 1 Current depression landscape
- Chapter 2 Novel therapeutic targets for treating affective disorders
- Chapter 3 Developing novel animal models of depression
- Chapter 4 Translational research in mood disorders
- Chapter 5 Defining depression endophenotypes
- Chapter 6 Genetic and genomic studies of major depressive disorder
- Chapter 7 Medicinal chemistry challenges in the design of next generation antidepressants
- Chapter 8 Application of pharmacogenomics and personalized medicine for the care of depression
- Index
Copyright page
Published online by Cambridge University Press: 19 October 2021
- Next Generation Antidepressants
- Next Generation Antidepressants
- Copyright page
- Contents
- Contributors
- Preface
- Abbreviations
- Chapter 1 Current depression landscape
- Chapter 2 Novel therapeutic targets for treating affective disorders
- Chapter 3 Developing novel animal models of depression
- Chapter 4 Translational research in mood disorders
- Chapter 5 Defining depression endophenotypes
- Chapter 6 Genetic and genomic studies of major depressive disorder
- Chapter 7 Medicinal chemistry challenges in the design of next generation antidepressants
- Chapter 8 Application of pharmacogenomics and personalized medicine for the care of depression
- Index
Summary
![Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Abook%3A9780511778414/resource/name/firstPage-9780511778414pre_pi-iv.jpg)
- Type
- Chapter
- Information
- Next Generation AntidepressantsMoving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders, pp. ivPublisher: Cambridge University PressPrint publication year: 2010